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Abstract
Background: The long chain N-acylhomoserine lactone (AHL) quorum sensing signal molecules released by Pseudomonas
aeruginosa have long been known to elicit immunomodulatory effects through a process termed inter-kingdom signaling.
However, to date very little is known regarding the exact mechanism of action of these compounds on their eukaryotic
targets.
Methodology/Principal Findings: The use of the membrane dipole fluorescent sensor di-8-ANEPPS to characterise the
interactions of AHL quorum sensing signal molecules, N-(3-oxotetradecanoyl)-L-homoserine lactone (3-oxo-C14-HSL), N-(3-
oxododecanoyl)homoserine-L-lactone (3-oxo-C12-HSL) and N-(3-oxodecanoyl) homoserine-L-lactone (3-oxo-C10 HSL)
produced by Pseudomonas aeruginosa with model and cellular membranes is reported. The interactions of these AHLs
with artificial membranes reveal that each of the compounds is capable of membrane interaction in the micromolar
concentration range causing significant modulation of the membrane dipole potential. These interactions fit simple
hyperbolic binding models with membrane affinity increasing with acyl chain length. Similar results were obtained with T-
lymphocytes providing the evidence that AHLs are capable of direct interaction with the plasma membrane. 3-oxo-C12-HSL
interacts with lymphocytes via a cooperative binding model therefore implying the existence of an AHL membrane
receptor. The role of cholesterol in the interactions of AHLs with membranes, the significance of modulating cellular dipole
potential for receptor conformation and the implications for immune modulation are discussed.
Conclusions/ Significance: Our observations support previous findings that increasing AHL lipophilicity increases the
immunomodulatory activity of these quorum compounds, while providing evidence to suggest membrane interaction plays
an important role in quorum sensing and implies a role for membrane microdomains in this process. Finally, our results
suggest the existence of a eukaryotic membrane-located system that acts as an AHL receptor.
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Introduction
Quorum sensing (QS) is the process through which bacterial
cells communicate enabling unicellular populations to coordinate
their response to an external stimulus as a function of population
density, for a review see [1]. Gram negative bacteria such as
Pseudomonas aeruginosa employ N-acylhomoserine lactone (AHL) QS
signal molecules. P. aeruginosa is an opportunistic human pathogen
responsible for causing infection in immune compromised indivi-
duals and is the leading cause of morbidity and mortality in cystic
fibrosis patients [2].
P. aeruginosa employs an AHL-dependent QS system employing
two LuxR/I pairs (LasR/I and RhlR/I) where LasR and RhlR are
transcriptional regulators which respond to the AHLs, N-(3-
oxododecanoyl)homoserine lactone (3-oxo-C12-HSL) and N-buta-
noylhomoserine lactone (C4-HSL) (Figure 1) respectively. These
are produced via the LasI and RhlI AHL synthases respectively
[3]. Although LasI directs the synthesis primarily of 3-oxo-C12-
HSL, the analogues 3-oxo-C10-HSL and 3-oxo-C14-HSL are also
produced, albeit at much lower levels [4]. The las and rhl systems
directly or indirectly regulate over 10% of the P. aeruginosa genome
[5] and are organized as a hierarchy in which LasR/3-oxo-C12-
HSL drives the expression of lasI (so constituting a positive
feedback loop) as well as rhlR and rhlI [6]. The las/rhl QS system
plays a key role in controlling virulence factor production, biofilm
maturation, swarming motility and the expression of antibiotic
efflux pumps [3].
P. aeruginosa AHLs have been detected in vivo during human
infections. They are readily detectable in sputum from cystic
fibrosis patients [7] although determining their physiological QS
concentration range is complicated as a consequence of their
susceptibility to alkaline [8] and/or enzymatic hydrolysis [9].
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oxo-C12-HSL (but not C4-HSL) antagonize growth and virulence
factor production in Gram positive bacteria such as Staphylococcus
aureus [10]. 3-oxo-C12-HSL may also contribute directly to the
outcome of host-pathogen interactions. 3-oxo-C12-HSL influences
smooth muscle contraction in blood vessels, exerts a marked
bradycardia [11] and modulates the junctional integrity and
paracellular permeability of epithelial cells [12]. It also modulates
host inflammatory and immune responses, (reviewed in [13,14]).
For example, at concentrations below 10 mM, 3-oxo-C12-HSL
reduced lipopolysaccharide (LPS)-induced production of the pro-
inflammatory cytokine IL-12 by monocytes [15] whereas pro-
inflammatory or pro-apoptotic effects were apparent at higher
concentrations in both macrophages and neutrophils [14,16,17].
The proliferation and function (cytokine production) of both
mitogen-stimulated (e.g., [18,19] and antigen-stimulated [20]) T
lymphocytes as well as antibody production by B lymphocytes
[15,19] are inhibited by 3-oxo-C12-HSL. Smith et al. [16] reported
that 3-oxo-C12-HSL induced activation of the pro-inflammatory
signaling components Cox-2 and NF-kB in transformed cell lines
however, this does not occur in primary cells in the absence of LPS
neither does 3-oxo-C12-HSL act via known pathogen pattern
recognition receptors [21]. In the absence of LPS, 3-oxo-C12-HSL
does induce phosphorylation of mitogen-activated protein kinase
(MAPK) p38, which could modulate cytokine production and also
potentiate TNFa-induced poly(adenosine 59-diphosphate-ribose)
(PARP) cleavage, a biochemical marker of apoptosis [22].
The direct target(s) of 3-oxo-C12-HSL in mammalian cells
have yet to be fully characterized. Since 3-oxo-C12-HSL enters
mammalian cells and retains intracellular activity [23,24], the
most likely receptor(s) for 3-oxo-C12-HSL has been suggested to be
intracellular. In this context, Jahoor et al. [25] obtained evidence to
suggest that 3-oxo-C12-HSL may bind to at least two isoforms
(PPARc and PPARb/d) of the peroxisome proliferator activated
receptors (PPARs). These belong to the nuclear hormone receptor
family which bind a range of endogenous and exogenous lipids
and play roles in inflammation and lipid metabolism. 3-oxo-C12-
HSL may therefore modulate NF-kB signaling via the direct
interaction with PPARs. Using an affinity matrix, Seabra et al.
[26] identified calprotectin as a target although this calcium
binding protein is unlikely to be the primary receptor for 3-oxo-
C12-HSL. In order for QS signal molecules to interact with
intracellular components they must first interact with the cell
membranes. Structure-activity assays of 3-oxo-C12-HSL have
revealed that optimal immune modulatory activity in a mouse
splenocyte proliferation assay in common with QS in P. aeruginosa
requires a C11 to C13 acyl chain, an intact homoserine lactone ring
and L-configuration at the chiral centre, suggesting lipophilicity is
important for QS immunosuppressive activity [18]. Based on these
observations and given the broad biological activity of 3-oxo-C12-
HSL in both pathogens and eukaryotic cells (particularly its action
on leukocytes), we have explored the interactions of long chain
AHLs with simple membranes and T lymphocytes. The potential
interactions of QS signal molecules with many types of membrane
have so far largely been ignored, although a recent study by
Lowery et al. [27] indicated they may have effects on bacterial
membrane permeability. This study presents evidence that 3-oxo-
C12 HSL and two close structural analogues, 3-oxo-C10-HSL and
3-oxo-C14-HSL are capable of insertion into the lipid bilayer in
both artificial membrane and Jurkat T-lymphocyte cell systems.
Although the AHL concentrations used are higher than those
reported in some human host samples e.g. sputum from cystic
fibrosis patients [7], the latter are likely to be an underestimate
since local AHL concentrations up to 600 mM have been detected
in culture supernatants of P. aeruginosa biofilms grown in vitro [4].
In order to determine whether these compounds are capable of
directly interacting with membranes they were studied using the
fluorescent probe di-8-ANEPPS (e.g. [28,29]). This technique
yields binding information such as affinity and overall binding
capacity as well as whether addition of AHLs impacts on the
membrane organization. The roles of QS acyl chain length (C10 to
C14) and cholesterol in membrane interactions are also investi-
gated and the potential roles of membrane microdomains (or rafts)
in immune modulation are discussed.
Results
AHL Immunosuppressive Activity is Dependent on
membrane affinity (Lipophilicity)
The concentrations of AHLs required to inhibit 50% prolifer-
ation (IC50) of human peripheral blood mononuclear cells
(PBMCs) was obtained from Chhabra et al 2003 [18]. These
data are plotted against a calculated LogP value in Table 1,
(calculated using the ACD/I-Lab Web service (ACD/LogP 12.0))
based on molecular structure. LogP is a measure of molecular
lipophilicity and is frequently used in the pharmaceutical industry
as an indicator of the likely bioavailability of a drug molecule.
Figure 1. Structures of common AHLs synthesized by P
aeruginosa. Structures of the most common AHL quorum sensing
compounds synthesized by Pseudomonas aeruginosa (C4-HSL, and 3-
oxo-C12-HSL) and those used in this study (3-oxo-C14-HSL, 3-oxo-C12-
HSL, COOH-3-oxo-C12-HSL and 3-oxo-C10-HSL).
doi:10.1371/journal.pone.0013522.g001
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r=20.895, p=0.016) exists between membrane affinity and
immunosuppressive activity.
The observation that AHLs with increasing chain length (and
therefore lipophilicity) impede cell proliferation to a greater extent
provides the first fully quantitative evidence to suggest that the
hydrophobic properties of AHLs play an important role in their
ability to inhibit immune cell function. This will most likely
manifest as an elevated ability to interact with biological
membranes, influencing membrane electrical potentials which
have been previously reported to effect indirectly membrane
protein function [29]. Alternatively AHLs with greater lipophilicity
will interact more readily with any hydrophobic binding pockets
that exist within receptor systems (i.e. either in a membrane or in a
soluble protein). The aim of this investigation is to provide
evidence which of these mechanisms AHLs elicit their well
documented immunomodulatory effects.
Interactions of AHLs with Phospholipid Membrane
Vesicles; Effects on Membrane Dipole Potential
Biological membranes, in addition to the well documented
transmembrane potential also possess two lesser known electrical
potentials termed the electrostatic membrane surface potential and
the membrane dipole potential (for an extensive review of this
trinity of membrane potentials see [30]). The membrane dipole
potential has a magnitude in the region of 300 mV and arises from
the orientation of dipoles at and just under the membrane surface.
On insertion of a molecule of interest into biological membranes,
this can cause a perturbation in this potential which can be
detected in both artificial and cellular membrane systems using the
electrochromic probe di-8-ANEPPS.
On this basis it is shown in Figure 3A & B that addition of 3-
oxo-C14-HSL, 3-oxo-C12-HSL and 3-oxo-C10-HSL to Phospho-
tidylcholine100% and Phosphatidylcholine70% Cholesterol30%
membranes vesicles led to a red shift in the excitation spectra of
di-8-ANEPPS. A red shift (with a minimum of ,440 nm and a
maximum of ,520 nm) is indicative of the ligands acting to
decrease the membrane dipole potential upon insertion into the
membrane. This finding is consistent with our previous work [29]
reporting that addition of reagents known to decrease the
membrane dipole potential, give rise to di-8-ANEPPS difference
spectra of similar profiles to those reported here.
Changes in the membrane dipole potential can be tracked over
time using the ratio of di-8-ANEPPS fluorescence at 460 nm and
520 nm excitation and a fixed emission (termed R(460/520)),
which is sensitive solely to variations of the local electric field due
to dipolar molecular properties. Upon titration of the AHLs into
these artificial membranes a concentration dependent decrease in
membrane dipole potential was observed as shown in Figure 3C.
These data were plotted as the incremental change of di-8-
ANEPPS fluorescence versus the concentration of AHL added
and fitted to various ‘binding’ models (eq. 1 & 2) as shown in
Figure 4A–C. Such observations are consistent with the interaction
and insertion of AHL molecules with the membrane vesicles. All
ligands were found to interact with both Phosphotidylcholine100%
and Phosphatidylcholine70%Cholesterol30% membranes via a
simple hyperbolic (i.e. non-cooperative) binding mechanism,
Figure 4D & E compare the dissociation constant (Kd) and
saturation point (Bmax) obtained in each case. Overall these figures
depict that as acyl chain length increases it leads to a decrease of
the observed the Kd, suggesting that longer chain AHLs have a
higher membrane affinity than the shorter chain variants. This was
found to be the case for both Phosphotidylcholine100% and
Phosphatidylcholine70%Cholesterol30% membranes. Titration of
the AHLs into membranes containing 30% cholesterol did not
result in a significant change in Kd (Figure 4D), however the
binding capacity of 3-oxo-C12 HSL and 3-oxo-C14 HSL (i.e.
saturation in fluorescence units) of Phosphatidylcholine70% Choles-
terol30% membranes was significantly greater than for Phosphatidyl-
choline100% membranes (p,0.05), suggesting that QS compounds
may be accumulating in membrane microdomains present in
Phosphatidylcholine70%Cholesterol30% membranes.
Addition of 200 mM COOH-3-oxo-C12 HSL to artificial mem-
branes (Figure 5A & B) was found to cause only a nominal red shift
in the di-8-anepps excitation spectrum. This shift was substantially
less than that observed for 3-oxo-C12 HSL. Titration of COOH-3-
oxo-C12 HSL into liposomes (Figure 5C) exhibited a dramatically
lower effect on the dipole potential than 3-oxo-C12 HSL and fit
poorly to both hyperbolic and sigmoidal models. This observation
Figure 2. A strong negative correlation is observed between
peripheral mononuclear cell proliferation and AHL lipophilic-
ity. The IC50 for human peripheral mononuclear cell proliferation
(PBMCs) isolated from three donors (* denotes n=2) in the presence of
AHLs of chain lengths between 8 and 14 carbons (values obtained from
[18]) exhibit a strong negative correlation (Pearsons r=20.895,
p=0.016) against the predicted octanol/water partition coefficient
(LogP) for each compound (calculated using ACD/i-Lab LogP algorithm
12.0). n=3, 6SEM. Projected LogP are given in Table 1.
doi:10.1371/journal.pone.0013522.g002
Table 1. Comparison of AHL octanol/water partition
coefficients.
QS molecule Projected LogP (±0.49)
3-oxo-C14-HSL 3.25
3-oxo-C13 HSL 2.74
3-oxo-C12-HSL 2.23
3-oxo-C11-HSL 1.72
3-oxo-C10-HSL 1.21
3-oxo-C8-HSL 0.19
COOH-3-oxo-C12-HSL 0.18
Comparison of AHL octanol/water partition coefficients (LogP) values calculated
from molecular structure using ACD/I-Lab LogP algorithm 12.0. Lipophilicity is
observed to significantly increase as AHL chain length increases from C8 to C14
(r=1.000, p,0.01, Spearman correlation). Addition of a carboxylic acid group to
the 3-oxo-C12 HSL acyl chain results in a marked reduction in projected LogP.
This compound was therefore expected to interact with membranes to a lesser
degree than the major AHL released by P. aeruginosa 3-oxo-C12 HSL.
LogP695% confidence interval shown.
doi:10.1371/journal.pone.0013522.t001
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substantially lower than 3-oxo-C12 HSL (Table 1).
Interactions of AHLs with T-Lymphocytes; Effects on
Membrane Dipole Potential
In the previous section it was shown that addition of AHLs to
simple phospholipid membranes resulted in a decrease in the
membrane dipole potential, which is indicative of these com-
pounds inserting into artificial membranes. As a result, it was of
interest to study their interactions with T-Lymphocytes which we
utilize as a model for the interaction of quorum molecules with
their prospective eukaryotic host cell systems.
Figure 6A indicates that addition of 3-oxo-C14-HSL, 3-oxo-C12-
HSL and 3-oxo-C10-HSL to this model cell system resulted in a
red shift in the excitation spectra of di-8-ANEPPS (all normalized
to controls containing the DMSO vector but not the QS) similar to
those observed previously with the artificial membrane systems.
This suggests that the AHLs used in this study were capable of
insertion into the plasma membrane of Jurkat T-lymphocytes
leading to changes in the dipole potential.
Resazurin reduction-based cell viability assays were conducted
as it is conceivable that treatment of the cells with AHLs may
affect viability. It was found however, that no significant effects on
cell viability take place at any of the concentrations utilized in our
studies (data not shown).
Figure 6B indicates that upon titration of di-8-ANEPPS labeled
Jurkat T-lymphocytes with AHLs, a similar decrease in the R(460/
520) parameter was observed as for titration with the artificial
membrane systems. These data were plotted and fitted as before
and are shown in Figure 7. It was found that 3-oxo-C14-HSL
exhibited a strong interaction with the cell membrane with both a
greater binding capacity (1.4060.11 compared to 0.8660.08,
p=0.02) and dissociation constant significantly less than 3-oxo-
C12-HSL (39 mM66 mM compared to 153 mM638 mM, p=0.04)
as determined by two tailed T test. The latter exhibited a more
complex binding reaction that was poorly described by Eq. 1. Eq.
2 however was found to be able to describe the binding isotherm
and this model indicates that cooperativity appears to be
occurring. The cooperativity index (sometimes referred to as the
Hill coefficient) for these studies was found to be 1.8760.27.
There are several possible interpretations of this finding, such as
that two 3-oxo-C12-HSL molecules come together on/in the
membrane to promote their respective interaction. There are,
however other explanations that accommodate this behavior of
which the most likely is that the membrane is modified by the
presence of the AHLs and this affects the subsequent binding of
further molecules (see below).
3-oxo-C10-HSL exhibited only a very slight interaction which
fitted neither binding model to a satisfactory degree (R
2=0.57).
Figure 8 indicates that pre-treatment of Jurkat T-lymphocytes
with 160 mM 3-oxo-C12 HSL caused a significant reduction in the
Bmax of P-glycoprotein (P-gp) for Saquinavir, in comparison to
cells treated with equivalent volumes of 0.5% DMSO solvent
(1.5360.04 compared to 1.9260.03, p=0.002) in addition to a
significant increase in Kd(39 mM61 mMc o m p a r e dt o3 4mM61u M ,
p=0.007). A slight but insignificant decrease in binding cooperativity
was also observed. Subsequent work has shown that pre-treatment
of lymphocytes with saquinavir has no significant influence on the
interaction of 3-oxo-C12 HSL with Lymphocytes (Data not shown).
These findings may therefore suggest that 3-oxo-C12 HSL mediated
lymphocyte membrane dipole potential modulation has indirectly
acted to change the activity of P-glycoprotein.
Figure 3. The interactions of AHLs with artificial membrane
systems perturbs the membrane dipole potential. Fluorescence
difference spectra obtained by subtracting di-8-ANEPPS excitation
spectra (lem=590 nm) of PC(100%) [A] or PC(70%)Cholesterol(30%) [B]
membrane vesicles (400 mM) from those obtained after these mem-
branes were exposed to the following QS molecules; 65 mM 3-oxo-C14-
HSL (thick dashed line), 200 mM 3-oxo-C12-HSL (solid black line) and
200 mM 3-oxo-C10-HSL (thin dashed and dotted line). Before subtrac-
tion, each spectrum was normalized to the integrated areas so that the
difference spectra would reflect only the spectral shifts. Each difference
spectrum was then normalised to a DMSO control (grey line) and a
three point moving average applied to reduce noise. In all experiments
the dye concentration was 10 mM and temperature was maintained at
37uC. [C] A dual wavelength ratiometric measurement of the dipole
potential variation in di-8-ANEPPS. Additions of 22 mM 3-oxo-C14-HSL or
equivalent volumes of DMSO were made to 400 mM PC(100%). Samples
were excited at 460 nm and 520 nm. Emission was read at 590 nm and
the ratio R(460/520) was calculated (shown). All experiments n=3.
doi:10.1371/journal.pone.0013522.g003
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The Interactions of AHLs with Artificial Membrane
Systems
The present study outlines the interactions between long chain
AHLs and a number of membrane types including live cells from
which it is possible to draw several important conclusions. First 3-
oxo-C14- HSL, 3-oxo-C12-HSL and 3-oxo-C10-HSL as shown in
Figure 4, were all observed to interact with PC100% and
PC70%Cholesterol30% artificial membrane systems. These model
membranes are taken to represent the most abundant lipid types
found in human cell types; their interaction profiles were found to
correspond to simple hyperbolic (saturatable) binding models
(Figures 3 & 4). Based on the well characterized responses of the
fluorescent probe we utilize in this study [30,31] we are able to
conclude from our observations that AHLs are capable of direct
insertion into biological membranes in the micromolar concen-
tration range.
The Interaction of AHLs with Cell Membranes
One virtue of using the di-8-ANEPPS probe is that it may also
be implemented with live cells as well as with our model
membrane systems. Analogous studies with T cells (Figure 7),
therefore, were found to indicate that all three AHLs are also
capable of insertion into the cell membrane in the micromolar
concentration range.
Previous work examining the immunomodulatory activity of
AHLs has suggested that insertion into T-lymphocyte membranes
is unlikely to be responsible for immunosuppressive effects of
3-oxo-C12 HSL at concentrations of less than 10 mM [20]. This
finding is corroborated by this study which suggests little
membrane association of 3-oxo-C12-HSL with T-Lymphocytes
at concentrations less than 30 mM. Above this concentration,
however, AHLs appear to have the ability to become inserted into
membranes. These findings are also in agreement with suggestions
that 3-oxo-C12-HSL acts via multiple signaling pathways [1].
The interaction of 3-oxo-C12-HSL with T-Lymphocytes was
found to be characterized most closely by a cooperative binding
mechanism. This suggests that two molecules may come together
on/in the membrane resulting in a fruitful binding/insertion
complex. As this effect was not observed in the artificial membrane
systems this observation implies that either 3-oxo-C12 HSL acts to
modify the more complex cell membrane which effects the
interaction of additional levels of 3-oxo-C12 HSL or that there
exists an as yet unidentified 3-oxo-C12 HSL receptor on the cell
surface. The former possibility is less likely as the cell membranes
possess both PC and cholesterol at about the levels we use in this
study. The latter possibility however, is consistent with previous
suggestions of the existence of a membrane receptor system for
AHLs. To date the putative eukaryotic receptors identified (PPARs
and calprotectin) [25,26] are both intracellular however the
existence of a membrane receptor has been suggested by Shiner
et al. [32] although its identity or nature has so far remained
elusive. Our present work therefore constitutes support for the
existence of a eukaryotic AHL membrane receptor which is active
at concentrations up to the micromolar range.
The concentrations of AHLs reported to influence membrane
dipole potential in this study are slightly greater than those
reported to cause significant inhibition of immune cell prolifera-
tion [18]. One possible suggestion that reconciles this observation
Figure 4. Binding profiles of the interactions of AHLs with artificial membrane systems. Binding profiles of [A] 3-oxo-C14-HSL, [B] 3-oxo-
C12-HSL and [C] 3-oxo-C10-HSL on titration to PC100% (N)o rP C 70%Cholesterol30% (D) di-8-ANEPPS labeled liposomes (400 mM) at 37uC( n = 5 )
normalised to DMSO controls. Profiles were fitted to simple hyperbolic and sigmoidal binding models (equations 1 and 2) and extra sum of squares F-
Tests were used to determine the best fitting in each case (all hyperbolic). [D] Average saturation points and [E] Average dissociation constant of the
best fitting models6SEM.
doi:10.1371/journal.pone.0013522.g004
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receptor mediated. The observation that the d-isomer of 3-oxo-
C12 HSL retains substantial immunomodulatory activity [18],
however, implies that indirect membrane interactions also play an
important role in the activity of these molecules. In addition,
Kaufmann et al. [33] reported more recently that many AHLs are
capable of decomposing to form substantial quantities of tetramic
acid breakdown products over the prolonged incubation times
used (24 to 48 hours in many proliferation assays). The
interactions of these tetramic acid breakdown products are as
yet poorly understood and may offer an additional explanation for
the greater than expected immunosuppressive activity of these
molecules.
Figure 5. Comparing the interactions of COOH-3-oxo-C12 HSL
and 3-oxo-C12 HSL with artificial membrane systems and their
effects on membrane dipole potential. Fluorescence difference
spectra obtained by subtracting di-8-ANEPPS excitation spectra
(lem=590 nm) of PC(100%) [A] or PC(70%)Cholesterol(30%) [B]
membrane vesicles (400 mM) from those obtained after these mem-
branes were exposed to either 200 mM 3-oxo-C12-HSL (dotted line,
n=5) or 200 mM COOH-3-oxo-C12-HSL (solid black line). Before
subtraction, each spectrum was normalized to the integrated areas so
that the difference spectra would reflect only the spectral shifts. Each
difference spectrum was then normalised to a DMSO control (dashed
line). In all experiments the dye concentration was 10 mMa n d
temperature was maintained at 37uC. [C] Binding profiles of 3-oxo-C12
HSL (m,N) and COOH-3-oxo-C12 HSL (D,#) on titration to PC100%
(circles) or PC70%Cholesterol30% (triangles) di-8-anepps labeled lipo-
somes (400 mM) at 37uC normalised to DMSO controls. Profiles were
fitted to simple hyperbolic and sigmoidal binding models (equations 1
and 2) and extra sum of squares F-Tests were used to determine the
best fitting in each case (3-oxo-C12 HSL was hyperbolic while COOH-3-
oxo-C12 HSL fit poorly to both models). All experiments n=36SEM.
doi:10.1371/journal.pone.0013522.g005
Figure 6. The interactions of AHLs with lymphocyte mem-
branes perturbs the membrane dipole potential. [A] Fluores-
cence difference spectra obtained by subtracting the di-8-ANEPPS
excitation spectra (lem=590 nm) of T Lymphocytes (40,000 cells/ml)
from those obtained after cells were exposed to the following QS
molecules 3-oxo-C14-HSL (thick line), 3-oxo-C12-HSL (dashed line) and 3-
oxo-C10-HSL (thin line). Before subtraction, each spectrum was
normalised to the integrated areas so that the difference spectra
would reflect only the spectral shifts before each difference spectra was
normalised to a DMSO control (not shown). A three point moving
average was then applied to reduce noise. [B] A dual wavelength
ratiometric measurement of the dipole potential variation in di-8-
A N E P P S .I nt h i se x a m p l ea d d i t i o n so f2 2 mM 3-oxo-C14-HSL or
equivalent volumes of DMSO were made to T-Lymphocytes (40,000
cells/ml) labeled with 10 mM di-8-ANEPPS. Samples were excited at
460 nm and 520 nm. The fluorescence was read at 590 nm and the
ratio R(460/520) was calculated (shown). All experiments n=3.
doi:10.1371/journal.pone.0013522.g006
Interacting AHLs with Membrane
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Membranes
The AHL acyl chain length was also studied with an increasing
chain length observed to augment significantly the membrane
binding affinity in both artificial and T-Lymphocyte membrane
systems. This behavior was anticipated as an increasing AHL acyl
chain length raises the molecular lipophilicity as indicated by the
projected octanol/water partition coefficient (Table 1). This
parameter is known as Log P and often used by developmental
pharmacologists to predict the lipophilicity of drug molecules
which has an important bearing on their bioavailability [34].
Classification of the LogP of the AHLs is of interest as it has been
previously reported that increasing AHL acyl chain length from
C8 to C14 increased its immunomodulatory activity in the
micromolar range [18] and this was found to negatively correlate
with LogP (Figure 2). Overall these studies provides further
evidence that the membrane interactions of AHLs may play an
important role in inter-kingdom signaling including the immune
modulatory effects of AHLs.
Figure 5 indicates that modification of the acyl chain to
introduce a negative charge (COOH-3-oxo-C12 HSL, projected
pKa=4.7860.1 calculated using ACD/pKa algorithm) signifi-
cantly reduces the ability of the compound to insert into artificial
membranes and modulate the dipole potential. This result was
predicted as the LogP of COOH-3-oxo-C12 HSL is substantially
lower than 3-oxo-C12 HSL (Table 1) and provides evidence that
changes in the di-8-anepps spectra observed occurred as a result
dipole potential modulation, when AHLs inserted into mem-
branes.
The Interaction of AHLs with Membrane Microdomains
A further sophistication to the systems that we investigate in the
present study includes preparation of membranes that we have
previously characterized and are known to exhibit microdomains
[35]. Such microdomains are rich in cholesterol and appear to be
similar to cellular structures known as membrane rafts [36]. The
presence of cholesterol containing microdomains on titration of
artificial membrane systems with 3-oxo-C12-HSL and 3-oxo-C14-
HSL was observed to increase significantly the saturation point in
comparison to membranes that were made up exclusively of
phosphatidylcholine. This suggests that the AHLs used in this
study may accumulate in cholesterol containing microdomains
which leads to a decrease in the membrane dipole potential. The
view that membrane microdomain localisation modulates the
behavior of receptor signaling is held by research groups in
addition to our own [35,37] and offers an interesting new
possibility regarding the activity of receptor controlled signaling
systems.
There is a growing body of evidence suggesting that the dipole
potential, which is higher in cholesterol rich microdomains than
the surrounding disordered membrane, is capable of modulating
membrane protein structure which may have implications for raft
associated cell signaling [29,30,38,39]. The decrease in membrane
dipole potential observed in this study could therefore stimulate the
indirect activation of signaling pathways by indirectly instigating a
conformational change in transmembrane receptor structure. This
principle could apply to both bacterial and eukaryotic organisms
and also offers an explanation as to why a primary AHL site of
action has so far remained elusive.
Towards Defining Mechanisms for Inter-kingdom
Signaling; Modulation of the Properties of a Membrane
Protein Receptor System by AHL-dependent Changes of
the Membrane Dipole Potential
The final section of this study is directed towards defining a
mechanism by which AHLs may elicit an inter-kingdom signaling
process. In other words we seek to demonstrate how a prospective
host cell (e.g. T cells) system may respond to the presence of AHLs
at appropriate concentrations as an illustration of how such
mechanisms may operate. In the present case we take advantage of
the fact that the binding of Saquinavir, a HIV-1 protease inhibitor
to the membrane protein P-gp is influenced by changes in the
Figure 7. Binding profiles of the interactions of AHLs with
Lymphocyte membranes. Binding profiles of 3-oxo-C14-HSL (D,
hyperbolic), 3-oxo-C12-HSL (N, sigmoidal) and 3-oxo-C10-HSL (6,
neither) on titration to di-8-ANEPPS labeled T-Lymphocytes (40,000
cells/ml) at 37uC normalised to DMSO controls. Profiles were fitted to
simple hyperbolic and sigmoidal binding models (equations 1 and 2)
and F-Tests were used to determine the best fitting model. In each
experiment n=3, 6SEM.
doi:10.1371/journal.pone.0013522.g007
Figure 8. Effect of decreasing membrane dipole potential on
membrane receptor conformation. Binding profiles of the P-
glycoprotein ligand Saquinavir with T-Lymphocytes (40,000 cells/ml)
after pre-treatment with 160 mM 3-oxo-C12 HSL (N) or an equivalent
volume of DMSO (final concentration did not exceed 0.5%) (D)a t3 7 uC.
Data were normalized for saquinavir additions by titrating cells with
equivalent volumes of DMSO (6, dashed lines). Profiles were fitted to
simple hyperbolic and sigmoidal binding models (equations 1 and 2)
and F-Tests were used to determine the best fitting model (sigmoidal
for 3-oxo-C12 HSL and DMSO pre-treatments). In each experiment n=3,
6SEM.
doi:10.1371/journal.pone.0013522.g008
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been shown to have a dependence on the lipidic content of the
membrane, particularly the sterol content [41] and appears to be
microdomain associated [42,43]. Previously it has been shown that
modification of the membrane dipole potential, through manip-
ulation of sterol concentrations, can influence the activity of P-gp
[29]. In the present paper we have shown that pre-treatment of T-
lymphocytes with micromolar concentrations of 3-oxo-C12 HSL
causes a significant reduction in the binding capacity of saquinavir
and increase in dissociation constant. These findings are consistent
with our previous work (see Asawakarn et al. [29]) that indicated
that the membrane dipole potential plays an important role in
modulating ligand-membrane interactions. We demonstrated that
disruption of cholesterol containing microdomains resulted in a
decrease in the binding capacity of P-gp for saquinavir. As a
similar trend was observed in the present work, this provides
further evidence to support the hypothesis that on insertion into
membranes, AHLs may act to disrupt cholesterol containing
membrane microdomains. This could have important conse-
quences on the activity of a plethora of raft-dependant membrane
proteins by no means limited to P-gp [44], although it is interesting
that P-gp activity is also associated with anti-microbial therapy.
P-gp belongs to the ABC-transporter protein superfamily and is
known to play a crucial role in the development of multiple-drug
resistance (MDR) [45]. The ability of AHLs to modulate PgP
activity would be advantageous to the bacteria and increase the
immune systems susceptibility to cytotoxic agents also released by
the pathogen. In addition, as MDR poses a significant problem for
the treatment of conditions including cancer, the search for
potential inhibitors has been intensive [45,46,47]. Our present
paper provides evidence of a membrane based mechanism of
action of AHLs on immune cells and suggests that through their
membrane interactions can act to modulate P-gp activity. AHLs or
their derivatives may therefore provide a novel drug template
family for the prevention of MDR.
The concentration of AHLs required to modulate immune cell
function in this way suggest that only cells in close proximity to the
bacterial biofilm would be subject to immune modulation through
these processes. This observation is in agreement with predictions
by Teplitski et al 2010 [48] who suggests the existence of such an
AHL gradient, up to micromolar concentrations under physiolog-
ical conditions. This could be of evolutionary advantage to P.
aeruginosa as under this system only immune cells which pose a
direct threat to the bacterial population are affected, allowing
more remote immune cells to retain their function, potentially
eliminating pathogens which would otherwise take advantage of a
compromised immune system, developing into secondary infec-
tions which would compete with P. aeruginosa.
Finally Chhabra et al. [18] have suggested that insertion of
AHLs into T-lymphocyte membranes causes immunosupression
through the inhibition of immunological synapse formation.
Membrane microdomains have been shown to play an important
role in the formation of the immunological synapse [49]. The
insertion of AHLs into biological membranes observed in this
study and the associated decrease in dipole potential could be
interpreted as evidence that this is the case.
Materials and Methods
Reagents
Egg phosphatidylcholine (PC) was supplied by Lipid Products
(UK). Di-8-ANEPPS was supplied by Invitrogen, UK. Saquinavir
was supplied by Roche (UK). AHLs were synthesized as described
previously [18,50]. Tissue culture reagents, cholesterol and all
other reagents were supplied at the highest purity available by
Sigma Aldrich (Poole, UK).
Membrane preparation and labeling with DI-8-ANEPPS
This technique is outlined more comprehensively in [29].
Briefly, PC100% and PC70%Cholesterol30% (molar ratios) were
dissolved in chloroform before drying under a stream of oxygen-
free nitrogen gas by rotary evaporation until a thin film was
formed. The lipid film was rehydrated with 280 mM sucrose,
10 mM Tris, pH 7.4 The resulting multilamellar solution was
freeze-thawed 5 times in liquid nitrogen and finally extruded 10
times through polycarbonate filters with pores 200 nm in diameter
(Nucleopore Corp., Pleasanton, USA) using an extruder (Lipex
Biomembranes Inc., Vancouver, Canada) according to the
extrusion procedure [51]. This resulted in a monodisperse,
unilamellar suspension of phospholipid vesicles. These were
labeled exclusively in the outer bilayer leaflet with Di-8-ANNEPS.
Here the phospholipid vesicles were incubated for at least
1.5 hours at 37uC in the dark in the presence of Di-8-ANEPPS
dissolved in ethanol.
Cell viability
An alamarBlue (Invitrogen; Carlsbad, CA) resazurin reduction
assay was used to measure of the number of viable and
proliferating cells and was conducted according to the manufac-
turer’s instructions. After incubation with AHLs compounds, 10%
alamarBlue was added to each well. Cells were incubated for 4 h
in a 5% CO2 incubator at 37uC. A negative control containing
culture medium and alamarBlue reagent without cells was
included. Fluorescence measurements were made by excitation
at 530–560 nm and measuring emission at 590 using a LS-55 plate
reader (Perkin Elmer, MA, USA).
Labeling of Jurkat T-Lymphocytes with Di-8-ANEPPS
The cells were cultured in RPMI 1640 medium supplemented
with 10% foetal bovine serum, L-glutamine (0.02M), penicillin
(100units/ml) and streptomycin (100 mg/ml) and maintained at
37uC and 5% CO2. Cells were counted using a trypan blue
exclusion assay before harvesting by centrifugation at 300 g for 5
minutes. Cells were then labeled with Di-8-ANEPPS according to
the methods outlined by Asawakarn et al. [29] as follows: 0.5 mM
Di-8-ANEPPS was added to a suspension containing 1610
6 cells
per ml
21 and incubated for 1.5 h at 37uC.
Fluorescence measurements
Fluorescence time courses were undertaken by adding desired
amounts of an experimental reagent under study to suspensions of
cells or phospholipid vesicles (400 mM lipid or 40,000 cells ml
21)
on a Fluromax-4 model spectrofluorimeter (HORIBA Jobin Yvon
Thermo Electron, UK). Di-8-ANEPPS spectra were obtained by
exciting the samples at 460 nm and 520 nm and measuring the
emission ratio at 590 nm [29,52]. The contribution of the dilution
effect to the fluorescence signal was corrected by using equivalent
liposome or cell suspensions and adding equivalent amounts of
DMSO solvent (final concentration did not exceed 0.6%). Any
changes in fluorescence signal were then subtracted from those
obtained with the quorum compounds. These data were fitted to
Equations 1 & 2 in order to determine the best description of the
molecular process. The model which best fit these data was
determined using an Extra sum-of-squares F-Test.
y~
Bmax:x
Kdzx
ð1Þ
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Bmax:xn
Kn
dzxn ð2Þ
Where y is the observed signal, Bmax is the 100% ligand binding
capacity (fluorescent units), Kd is the affinity of the QS compound
for the membrane in concentration units and n represents the hill
coefficient, i.e. as an index of cooperativity. Unless otherwise
stated all experiments are reported from at least 3 replicates ie.
n=3.
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